ANTINEOPLASTICS TOXICITY
Clinical trials for ANTINEOPLASTICS TOXICITY explained in plain language.
Never miss a new study
Get alerted when new ANTINEOPLASTICS TOXICITY trials appear
Sign up with your email to follow new studies for ANTINEOPLASTICS TOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo could help bladder cancer patients keep their bladder
Disease control Recruiting nowThis study is testing whether giving two immunotherapy drugs before surgery can shrink bladder tumors enough to avoid removing the bladder entirely. The trial will enroll 90 adults with muscle-invasive bladder cancer who are not receiving standard chemotherapy. Researchers will c…
Matched conditions: ANTINEOPLASTICS TOXICITY
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Cancer survivors ask: can we stop the heart pills?
Disease control Recruiting nowThis study aims to find out if cancer survivors can safely stop taking heart failure medications after their heart function has returned to normal following cancer treatment side effects. Researchers will compare two groups: one that continues medications and one that stops them,…
Matched conditions: ANTINEOPLASTICS TOXICITY
Phase: PHASE4 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC